Lenalidomide plus PD-1/PD-L1 inhibitors in combination synergistically increased cytotoxic effects against MM cells via interferon γ secretion by effector cells as well as promoted direct apoptotic MM cell death [203]. The gene discussed is CD274; the disease is Miyoshi myopathy.